Skip to main content
. 2013 May 1;33(8):1225–1234. doi: 10.1038/jcbfm.2013.71

Figure 4.

Figure 4

Effect of AMD3100 on CD34+ cell mobilization after transient middle cerebral artery occlusion (tMCAO). Effect of AMD3100 treatment on CD34+, CD34+/CD3+, CD34+/CD4+, and CD34+/CD3+/CD4+ cells in the blood 6 days after tMCAO or sham operation. Values are presented as percentage of total CD34+ cells as the median with the 25th to 75th percentiles and 95% confidence interval.